Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-21-002227

COO, GENERAL COUNSEL &CORP SEC gave up 459 shares (to pay taxes)

  • COO, GENERAL COUNSEL &CORP SEC acquired 1,562 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC 2021-04-30 Option exercise +1,562 27,639 D: show line 1 in the form
Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC 2021-04-30 Shares withheld for taxes −459 $2.18 $1,001 27,180 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC 2021-04-30 Option exercise · Restricted Stock Units −1,562 10,938 D: show line 3 in the form
Loading xslF345X03/form4-05032021_100502.xml…